Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q2 2025)

As of Jun 30, 2025, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Aug 13, 2025. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q2 2025, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q2 2025
00183L201
ANGI
Buy
+200,823
Q2 2025
40090E106
Grupo Cibest
Buy - Position Entry
+387,000
Q2 2025
573134103
Marti Technologies
Buy
+45,412
Q2 2025
62548M209
Claritev
Buy
+11,348
Q2 2025
690145206
Outset Medical
Sell
-17,346
Q2 2025
741623102
Primo Brands
Buy
+224,943
Q2 2025
85423L103
StandardAero
Buy
+998,200
Q2 2025
87318A101
TWFG
Sell
-17,444
Q2 2025
AA
Alcoa Corporation
Buy
+781,751
Q2 2025
AAAU
Goldman Sachs Physical Gold ETF
Sell
-637,000
Q2 2025
AADI
Aadi Bioscience, Inc.
Sell
-3,900
Q2 2025
AAL
American Airlines Group, Inc.
Sell
-11,031,561
Q2 2025
AAME
Atlantic American Corporation
Buy
+300
Q2 2025
AAOI
Applied Optoelectronics, Inc.
Sell - Position Exit
-359,879
Q2 2025
AAP
Advance Auto Parts Inc.
Buy - Position Entry
+115,250
Q2 2025
AAPL
Apple Inc.
Buy
+2,281,886
Q2 2025
AAT
American Assets Trust, Inc.
Sell
-187,300
Q2 2025
AAXJ
iShares MSCI All Country Asia e
Sell
-34,700
Q2 2025
ABBV
AbbVie Inc.
Buy
+739,900
Q2 2025
ABCB
Ameris Bancorp
Buy
+60,600
Q2 2025
ABCL
AbCellera Biologics Inc.
Buy
+413,400
Q2 2025
ABEO
Abeona Therapeutics Inc.
Buy
+168,400
Q2 2025
ABEV
Ambev S.A.
Buy
+4,824,400
Q2 2025
ABL
Abacus Life, Inc.
Buy
+159,000
Q2 2025
ABM
ABM Industries Incorporated
Sell
-11,400
Q2 2025
ABNB
Airbnb, Inc.
Sell
-1,530,882
Q2 2025
ABOS
Acumen Pharmaceuticals, Inc.
Sell
-10,112
Q2 2025
AC
Associated Capital Group, Inc.
Sell
-200
Q2 2025
ACA
Arcosa, Inc.
Sell
-2,400
Q2 2025
ACAD
ACADIA Pharmaceuticals Inc.
Buy
+70,699
Page 1 of 123